Schedule 13G ownership disclosure
MOLECULIN BIOTECH INC
Security class unavailable · CUSIP: 60855D101
Event date: 2020-11-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,787,254
- Percent of class
- 7.5200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-124610
- Form type
- SC 13G
- Filer
- Lincoln Park Capital Fund, LLC
- CIK
- CIK 1592644
- Filed
- Nov 13, 2020
- Reporting period
- Nov 12, 2020
- Description
- Schedule 13G beneficial ownership